The immune landscape of GBM is further shaped by cytokines, chemokines, and immune checkpoint molecules, such as programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), which regulate immune cell activation and function. The gene discussed is PDCD1; the disease is glioblastoma.